Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Author(s):
Seyed Moayed AlavianSeyed Moayed Alavian1,*, Masoud Ahmadzad AslMasoud Ahmadzad Asl2, maryam keshvarimaryam keshvari3, Bita BehnavaBita Behnava4, bashir hajibeigibashir hajibeigi5
1Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
2Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
3Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
4Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
5Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran

Hepatitis Monthly:Vol. 6, issue 1; e92946
Published online:Mar 31, 2006
Article type:Research Article
Received:May 05, 2019
Accepted:Mar 31, 2006
How to Cite:Alavian SM, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. doi:

References

  • 1.
    The references are available in the PDF file.

Similar Articles

31
May
2004

Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

Seyed Moayed Alavian,
Ali Kabir,
Behzad Hajarizadeh,
Mohsen Nayebpour Pharm,
bashir hajibeigi,
Taher Doroudi
,et al.

Alavian SM, Kabir A, Hajarizadeh B, Nayebpour Pharm M, hajibeigi B, et al. Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C. Hepat Mon. 2004;4(6):e92940. doi:

1
Jan
2006

Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

SM Alavian,
A Kabir,
B Hajarizadeh,
M Nayebpour,
T Dorodi,
FE Baralle

Alavian S, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, et al. Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study. Shiraz E-Med J. 2006;7(1):20390. doi:

30
Sep
2004

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Nasser Ebrahimi Daryani,
Babak Haghpanah,
Ali Reza Sayyah,
Ali Asad Hashtroudi,
Mohammad Bashashati,
Parisa Poursamimi
,et al.

Daryani N, Haghpanah B, Sayyah A, Hashtroudi A, Bashashati M, et al. The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial. Hepat Mon. 2004;4(7):. doi:

30
Sep
2004

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Moayed Alavian,
Behzad Hajarizadeh,
Bashir Hajibeigi,
Taher Doroudi,
Amir Kambiz Hamadanizadeh,
Koroush Abar

Alavian S, Hajarizadeh B, Hajibeigi B, Doroudi T, Hamadanizadeh A, et al. Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian. Hepat Mon. 2004;4(7):. doi:

31
May
2004

Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report

Shahnaz Sali,
Masoud Ahmadzad Asl,
Seyed Moayed Alavian,
Shahnaz Sali,
Masoud Ahmadzad Asl,
Seyed Moayed Alavian

Sali S, Ahmadzad Asl M, Alavian SM, Sali S, Ahmadzad Asl M, et al. Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report. Hepat Mon. 2004;4(6):e92938. doi:

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles